Introduction
Five decades ago, Ashbaugh and colleagues first used the term “syndrome of acute respiratory distress” [ARDS] to describe 12 patients with respiratory failure [1]. The hallmarks of the syndrome were hypoxemia refractory to supplemental oxygen, diffuse radiographic opacities, and histologic evidence of diffuse alveolar damage [DAD] in most but not all fatal cases. Over three decades later, the widely adopted American–European Consensus Conference [AECC] definition of ARDS facilitated research and aided cross-study comparison and translation of research findings to clinical practice [2]. The new Berlin definition refined the AECC definition by explicitly defining acute onset. Since the majority of patients destined to develop ARDS do so within the first 72 h after recognition of a clinical risk factor, with the rest progressing within a week, the Berlin definition explicitly defined “acute onset” as 7 days [3]. It defined mild, moderate, and severe ARDS with explicit ranges of PaO2/FiO2. It also attempted to improve the poor interobserver agreement on the AECC radiographic criteria by explicitly describing qualifying opacities and providing example radiographs [4, 5]. As left atrial hypertension and ARDS may coexist, the Berlin definition abandoned the pulmonary artery occlusion pressures exclusion [6]. Finally, the Berlin definition added the requirement for a known clinical risk factor [e.g., pneumonia, sepsis, trauma, etc.], and if none is apparent then additional testing is recommended to exclude congestive heart failure. Both the AECC and the Berlin definition retain the central elements of Ashbaugh’s original description. However, both the definitions have only moderate sensitivity and specificity for identifying patients who have DAD on post mortem examination, even in the severe subgroup of the Berlin definition [7, 8]. Moreover, lung biopsy findings in patients with what is assumed to be unresolving ARDS frequently show a number of pathologic entities other than DAD. From our clinical experience, we discuss ten of these clinical entities that may be mistaken for ARDS.
Ten diseases that may be mistaken for ARDS
Table 1 lists ten clinical entities that may be mistaken for ARDS. While it is beyond the scope of this brief report to outline a diagnostic approach to all of these entities, we offer a few observations from clinical experience. While some entities may present in an accelerated time course of several–many days, which would be consistent with the time course for ARDS, more typically they present with a longer time course. This should raise suspicion that the clinical problem is something other than ARDS. Another clinical clue is the absence of a known clinical risk factor for ARDS; or if a clinical risk factor has been identified and treated appropriately [for example, pneumonia], progression should stimulate consideration of other entities. Occasional signs and symptoms [e.g., hemoptysis, association with rheumatologic conditions, or with glomerulonephritis] may distinguish an entity from ARDS. There is substantial overlap in the radiographic findings between ARDS and these entities, but some findings may distinguish some entities from ARDS [e.g., honeycombing in pulmonary fibrosis and cavitary nodules in granulomatosis with polyangiitis] [9]. Some bronchoalveolar lavage findings may also help to distinguish some of these entities from ARDS as noted in Table 1 [10]. A single-center study suggested that open lung biopsy in patients with suspected ARDS may improve outcomes if it contributes to management [11]. In general, the combination of a careful history and physical examination, serologic testing for connective tissue disease and vasculitis, computed tomography [CT] scan, and bronchoscopy findings as presented in Table 1 should limit the need for open lung biopsy to establish a diagnosis in enigmatic cases that masquerade as ARDS.
Table 1 Ten clinical entities that may be mistaken for acute respiratory distress syndrome
Full size table
Implications for treatment
If a patient with one of these ten ARDS mimics requires mechanical ventilation, there may be a substantial risk of ventilator-induced lung injury because inflammatory processes increase the vulnerability of the lung parenchyma to mechanical stress. Moreover, the volume of aerated lung is reduced, making the aerated lung vulnerable to overdistension. Therefore, we recommend using a lung-protective approach, as in ARDS, with an initial tidal volume goal of approximately 6 ml/kg predicted body weight [12]. The optimal level of positive end-expiratory pressure [PEEP] in ARDS is still controversial, and we know of no data to guide us in the use of PEEP in patients with the entities described in Table 1.
Whereas use of steroids in unresolving ARDS remains a matter of debate [13, 14], some of the disease entities in Table 1 should prompt clinicians to start steroids without delay. This holds true for systemic lupus, alveolar hemorrhage complicating polyangiitis and Goodpasture’s syndrome, acute eosinophilic pneumonia, and most patients with nonspecific interstitial pneumonitis. Other diagnoses will require additional therapies [such as plasmapheresis and immunosuppressive therapy for Goodpasture’s syndrome and additional immunosuppressive therapy for polyangiitis]. Some require a careful search for an environmental or occupational exposure [hypersensitivity pneumonitis] or an offending drug exposure to prevent recurrence or progression and improve clinical outcomes. Close interaction with a pneumologist and/or a physician skilled in systemic diseases is often helpful to coordinate care.
The distinction between ARDS and some of the other entities may have important prognostic implications. Although the mortality rate from ARDS is high, most patients recover from the acute process, and many return to productive lives. In contrast, idiopathic pulmonary fibrosis [IPF] progresses relentlessly, leading to irreversible respiratory failure. If the diagnosis of IPF can be established before onset of respiratory failure, patients can be counseled about their condition and make more informed decisions about end-of-life care.
References
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE [1967] Acute respiratory distress in adults. Lancet 2:319–323
Article CAS PubMed Google Scholar
Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R [1994] The American–European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
Article CAS PubMed Google Scholar
Hudson LD, Milberg JA, Anardi D, Maunder RJ [1995] Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293–301
Article CAS PubMed Google Scholar
Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, Rhodes A, Slutsky AS, Vincent JL, Rubenfeld GD, Thompson BT, Ranieri VM [2012] The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 38:1573–1582
Article PubMed Google Scholar
Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS [2012] Acute respiratory distress syndrome: the Berlin definition. JAMA 307:E1–E8
Google Scholar
Wheeler AP, Bernard GR, Thompson BT, Schoenfeld D, Wiedemann HP, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL, the National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome [ARDS] Clinical Trials Network [2006] Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. New Engl J Med 354:2213–2224
Article PubMed Google Scholar
Esteban A, Fernandez-Segoviano P, Frutos-Vivar F, Aramburu JA, Najera L, Ferguson ND, Alia I, Gordo F, Rios F [2004] Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med 141:440–445
Article PubMed Google Scholar
Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Penuelas O, Cortes-Puch I, Cardinal-Fernandez P, Lorente JA, Frutos-Vivar F [2013] Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med 187:761–767
Article PubMed Google Scholar
Hodnett PA, Naidich DP [2013] Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. Am J Respir Crit Care Med 188:141–149
Article PubMed Google Scholar
King TE Jr [2005] Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med 172:268–279
Article PubMed Google Scholar
Papazian L, Doddoli C, Chetaille B, Gernez Y, Thirion X, Roch A, Donati Y, Bonnety M, Zandotti C, Thomas P [2007] A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 35:755–762
Article PubMed Google Scholar
ARDSnet [2000] Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network, ARDSnet. N Engl J Med 342:1301–1308
Article Google Scholar
Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M [2006] Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684
Article CAS PubMed Google Scholar
Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A [2008] Corticosteroids in the prevention and treatment of acute respiratory distress syndrome [ARDS] in adults: meta-analysis. BMJ 336:1006–1009
Article PubMed Central PubMed Google Scholar
Download references
Conflicts of interest
On behalf of all authors the corresponding author states that there is no conflict of interest related to this manuscript.
Author information
Authors and Affiliations
Réanimation Médicale, Hôpital de la Croix-Rousse, Lyon, France
Claude Guérin
Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Taylor Thompson
Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, USA
Roy Brower
Authors
- Claude Guérin
You can also search for this author in PubMed Google Scholar
- Taylor Thompson
You can also search for this author in PubMed Google Scholar
- Roy Brower
You can also search for this author in PubMed Google Scholar
Corresponding author
Correspondence to Claude Guérin.
Rights and permissions
About this article
Cite this article
Guérin, C., Thompson, T. & Brower, R. The ten diseases that look like ARDS. Intensive Care Med 41, 1099–1102 [2015]. //doi.org/10.1007/s00134-014-3608-x
Download citation
Received: 06 December 2014
Accepted: 09 December 2014
Published: 20 December 2014
Issue Date: June 2015
DOI: //doi.org/10.1007/s00134-014-3608-x
Keywords
- Idiopathic Pulmonary Fibrosis
- Clinical Risk Factor
- Diffuse Alveolar Damage
- Pulmonary Artery Occlusion Pressure
- Open Lung Biopsy